Extracellular DNA in blood products and its potential effects on transfusion.

Bioscience Reports
Li YangYuanshuai Huang

Abstract

Blood transfusions are sometimes necessary after a high loss of blood due to injury or surgery. Some people need regular transfusions due to medical conditions such as haemophilia or cancer. Studies have suggested that extracellular DNA including mitochondrial DNA present in the extracellular milieu of transfused blood products has biological actions that are capable of activating the innate immune systems and potentially contribute to some adverse reactions in transfusion. From the present work, it becomes increasingly clear that extracellular DNA encompassed mitochondrial DNA is far from being biologically inert in blood products. It has been demonstrated to be present in eligible blood products and thus can be transfused to blood recipients. Although the presence of extracellular DNA in human plasma was initially detected in 1948, some aspects have not been fully elucidated. In this review, we summarize the potential origins, clearance mechanisms, relevant structures, and potential role of extracellular DNA in the innate immune responses and its relationship with individual adverse reactions in transfusion.

References

Aug 1, 1975·The Journal of Clinical Investigation·C R Steinman
Jan 1, 1991·Annual Review of Genetics·O E Landman
Jun 1, 1987·European Journal of Cancer & Clinical Oncology·M StrounP A Maurice
Oct 14, 1969·Journal of Molecular Biology·S Borenstein, E Ephrati-Elizur
May 1, 1967·British Journal of Haematology·P Wolf
Mar 1, 1984·The Journal of Clinical Investigation·C R Steinman
Jun 1, 1980·Biulleten' eksperimental'noĭ biologii i meditsiny·Z I VolkovaO M Folomeeva
Dec 1, 1980·The Journal of Clinical Investigation·L Raptis, H A Menard
Sep 8, 1994·The New England Journal of Medicine·N M HeddleJ G Kelton
Sep 1, 1995·Biologicals : Journal of the International Association of Biological Standardization·M DuxburyJ Wright
Nov 1, 1995·Current Opinion in Hematology·N M Heddle
Aug 30, 2000·Lancet·D Hochhauser
Nov 6, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·M StrounP Anker
Dec 17, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Christine P-Y ChangJames T Wu
Mar 26, 2003·Clinical Chemistry·Timothy H RainerY M Dennis Lo
May 1, 1960·Transactions of the New York Academy of Sciences·J BENOITC VENDRELY
Mar 6, 2004·Science·Volker BrinkmannArturo Zychlinsky
Jun 3, 2004·Nature Reviews. Immunology·Seung-Yong Seong, Polly Matzinger
Dec 9, 2004·International Immunology·Kiyoshi Takeda, Shizuo Akira
Jun 25, 2005·Clinical Chemistry·Svetlana N TamkovichPavel P Laktionov
Dec 15, 2005·The International Journal of Biochemistry & Cell Biology·Markus NapireiHans Georg Mannherz
Jul 11, 2006·Biochemistry. Biokhimii︠a︡·B P ChelobanovV V Vlasov
Oct 6, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nobuyasu SuzukiYoshimi Homma
Mar 18, 2008·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Lisa J CardoJeanne Salata
Jun 17, 2008·Metabolism: Clinical and Experimental·Heather KirkKenneth J Eilertsen
Sep 4, 2008·Journal of Thrombosis and Thrombolysis·Vijayalakshmi KunadianC Michael Gibson
Sep 24, 2008·Immunologic Research·Tsan Xiao
Oct 1, 2008·Critical Care Medicine·Paul E Marik, Howard L Corwin
Oct 8, 2008·Annals of the New York Academy of Sciences·Aleksei V ErmakovNatalya N Veiko
Mar 24, 2009·Annual Review of Immunology·Charles A Dinarello
Jul 18, 2009·Cell Death and Differentiation·S YousefiH U Simon
Aug 8, 2009·Science·Carl Zimmer
Mar 24, 2010·Annual Review of Immunology·Kenneth L RockHajime Kono

❮ Previous
Next ❯

Citations

Mar 13, 2021·Hämostaseologie·Fabrice CognassePeter Larsen
Nov 24, 2020·ACS Omega·Sankarganesh Krishnamoorthy, Robert H Grubbs

❮ Previous
Next ❯

Methods Mentioned

BETA
DNA Assay
transmission electron microscopy
electron microscopy

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

The American Journal of Nursing
Margaret CarmanSara Marie McClintock
Schweizerische medizinische Wochenschrift
S P Hauser, U E Nydegger
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Farheen KarimMohammad Khurshid
© 2021 Meta ULC. All rights reserved